MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
批准号:
2067925
负责人:
KENNETH L BOST
金额:
$13.65万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 1997-07-31
关键词:
MHC class II antigen RNase protection assay Salmonella typhimurium antireceptor antibody antisense nucleic acid bactericidal immunity bioassay enzyme linked immunosorbent assay gene expression immunofluorescence technique inhibitor /antagonist laboratory mouse leukocyte activation /transformation macrophage monokines neurotransmitter receptor nucleic acid sequence phagocytosis polymerase chain reaction radioimmunoassay receptor expression recombinant proteins substance P tachykinin tissue /cell culture
中文摘要
描述:(改编自申请人摘要):巨噬细胞是
英文摘要
DESCRIPTION: (Adapted from the Applicant's abstract): Macrophages are
critically important for phagocytosis and killing of microbes, for
secreting cytokines to activate leukocytes, and for presenting antigen
to MHC compatible T lymphocytes. Since activated macrophages perform
these functions with much greater efficiency, understanding the events
required to activate these cells is of considerable importance. While
cytokines, such as interferon-gamma, have important macrophage
activating factors, little attention has been given to the peptide,
substance P. This peptide is found in tissues undergoing inflammatory
processes and in normal lymphoid tissues. It is also clear that
macrophages express substance P receptors. The overall goal of this
project is to determine the significance of substance P production and
substance P receptor expression by macrophages using in vitro and in
vivo models of macrophage activation. Specifically, nuclease protection
assays and radioimmunoassays will be performed to quantify
preprotachykinin mRNA expression and substance P secretion, respectively.
These studies are of extreme importance since they challenge the current
view that substance P is solely a product of neuronal cells. The
ability of macrophages to secrete substance P and express receptors for
this peptide suggest that autocrine mechanisms can occur.
Unfortunately, it is not possible to definitively address the role of
substance P receptor expression in macrophage activation since reagents
to detect this receptor are not available. To this end, the murine
macrophage substance P receptor will be sequenced using the dideoxy
chain termination method, and cloned receptor fragments used to develop
sensitive quantitative competitive-reverse transcribed PCR (QC-RT-PCR).
These assays will quantify receptor mRNA expressed by macrophages
activated in vitro or in vivo. Using a protein expression system, it
will be possible to express recombinant receptor protein for use as an
immunogen. Antibodies specific for the macrophage substance P receptor
and I-125 labelled substance P will be used to quantify receptor
expression on macrophages activated in vitro and in vivo. The ability
of activated macrophages to up regulate substance P receptors, strongly
suggests a role in macrophage activation. To prove this hypothesis, the
effect substance P has on several critical macrophage functions will be
determined. These functions include: 1) phagocytosis and killing of
Salmonella typhimurium; 2) expression of monokine, class II MHC, and
substance P receptor mRNAs as quantified by QC-RT-PCR; 3) secretion of
monokines quantified by ELISA and bioassays; and 4) cell surface
expression of class II MHC and substance P receptor proteins using
immunofluorescence. To prove specificity and significance of the
substance P induced effects, antagonists of the response will be used.
These antagonists will include: 1) a peptide antagonist (Spantide II);
2) anti-substance P receptor antibodies; and 3) anti-sense
oligonucleotides. Ultimately the ability of substance P antagonists to
increase the pathogenicity of the intracellular pathogen, Salmonella
typhimurium, will be determined using a murine model. Together these
studies are likely to demonstrate that the substance P- substance P
receptor interaction is one of considerable importance for the
activation of macrophages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Platform for practical delivery of oral autoantigens as co-therapies for neurolog
-
批准号:8640510
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2014
-
负责人:KENNETH L BOST
-
依托单位:
Induced Autoantigen Expression Exacerbates EAE
-
批准号:7779144
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2010
-
负责人:KENNETH L BOST
-
依托单位:
Induced Autoantigen Expression Exacerbates EAE
-
批准号:8013914
-
项目类别:
-
资助金额:$21.17万
-
财政年份:2010
-
负责人:KENNETH L BOST
-
依托单位:
MDMA alters immunity to infections of the peripheral and central nervous systems
-
批准号:7389648
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2007
-
负责人:KENNETH L BOST
-
依托单位:
MDMA alters immunity to infections of the peripheral and central nervous systems
-
批准号:7798952
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2007
-
负责人:KENNETH L BOST
-
依托单位:
MDMA alters immunity to infections of the peripheral and central nervous systems
-
批准号:7608715
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2007
-
负责人:KENNETH L BOST
-
依托单位:
MDMA alters immunity to infections of the peripheral and central nervous systems
-
批准号:7251076
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:KENNETH L BOST
-
依托单位:
Edible adjuvant expressed in transgenic soybeans
-
批准号:6814707
-
项目类别:
-
资助金额:$6.63万
-
财政年份:2004
-
负责人:KENNETH L BOST
-
依托单位:
An edible adjuvant expressed in transgenic soybeans
-
批准号:6953761
-
项目类别:
-
资助金额:$6.63万
-
财政年份:2004
-
负责人:KENNETH L BOST
-
依托单位:
Limited IL-12B2 receptor expression during salmonellosis
-
批准号:6632243
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:KENNETH L BOST
-
依托单位:
Limited IL-12B2 receptor expression during salmonellosis
-
批准号:6511235
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:KENNETH L BOST
-
依托单位:
Limited IL-12B2 receptor expression during salmonellosis
-
批准号:6400720
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6540288
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6465478
-
项目类别:
-
资助金额:$6.99万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6394487
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6165301
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:2067926
-
项目类别:
-
资助金额:$13.98万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:6373276
-
项目类别:
-
资助金额:$20.01万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:2067927
-
项目类别:
-
资助金额:$14.54万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:2886762
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
海外基金